Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Epidemiology and Infection|June 1, 1993
Occurrence of FIme plasmids in multiply antimicrobial-resistant Escherichia coli isolated from urinary tract infectionP A Riley, E J Threlfall, T Cheasty, et al.
Bioorganic & Medicinal Chemistry|June 16, 2001
Melanocyte-Directed enzyme prodrug therapy (MDEPT): development of second generation prodrugs for targeted treatment of malignant melanomaA M Jordan, T H Khan, H Malkin, et al.
Biochemical Pharmacology|August 17, 1994
Catechol-O-methyltransferase as a target for melanoma destruction?N P Smit, A J Latter, S Naish-Byfield, et al.
British Journal of Cancer|July 17, 1999
Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ culturesA Casas, A M Batlle, A R Butler, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Melanogenesis-targeted anti-melanoma pro-drug development: effect of side-chain variations on the cytotoxicity of tyrosinase-generated ortho-quinones in a model screening systemP A Riley, C J Cooksey, C I Johnson, et al.
Developments in Biological Standardization|January 1, 1985
The production and properties of a tissue plasminogen activator from normal epithelial cells grown in microcarrier cultureJ B Griffiths, I D McEntee, A Electricwala, et al.
Biochimica Et Biophysica Acta|October 13, 1989
A pulse radiolysis investigation of the oxidation of indolic melanin precursors: evidence for indolequinones and subsequent intermediatesC Lambert, J N Chacon, M R Chedekel, et al.
The Journal of Biological Chemistry|October 23, 1997
Evidence of the indirect formation of the catecholic intermediate substrate responsible for the autoactivation kinetics of tyrosinaseC J Cooksey, P J Garratt, E J Land, et al.
Clinical Pharmacology and Therapeutics|August 1, 1978
Clinically significant adverse effects in a Phase 1 testing programC J Zarafonetis, P A Riley, P W Willis, et al.
Pigment Cell Research|September 13, 2006
Dopaquinone redox exchange with dihydroxyindole and dihydroxyindole carboxylic acidR Edge, M d'Ischia, E J Land, et al.
Pageof 12